27. [IF=5.062] Jia Liu et al."Multi-unit pellet drug delivery system of Danggui Decoction extracts for chemoprevention of IBD-associated colorectal cancer in rats."JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY.2022 Oct;:103884 26. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950 25. [IF=4.36] Xiaoli Zhao et al."Transcriptomic study of the mechanism by which the Kai Yu Zhong Yu recipe improves oocyte quality in a stressed mouse model."J Ethnopharmacol. 2021 Oct;278:114298 24. [IF=4.36] Shi-Jie Bi et al."Network pharmacology-based study on immunomodulatory mechanism of danggui-yimucao herb pair for the treatment of RU486-induced abortion."J Ethnopharmacol. 2022 Jan;282:114609 23. [IF=5.81] Yan Tao et al."Ligustilide Prevents Radiation Enteritis by Targeting Gch1/BH4/eNOS to Improve Intestinal Ischemia."Front Pharmacol. 2021 Apr;0:893 22. [IF=5.923] Jia Liu et al."Supercritical Fluid Extract of Angelica sinensis and Zingiber officinale Roscoe Ameliorates TNBS-Induced Colitis in Rats."Int J Mol Sci. 2019 Jan;20(15):3816 21. [IF=6.529] Yan He et al."Pharmacokinetics and biotransformation investigation in beagle dog of active compounds from naoxintong capsule."Biomed Pharmacother. 2021 Jan;133:110940 20. [IF=4.379] Chen Wei-Ren et al."Phthalide Derivatives from Angelica Sinensis Decrease Hemoglobin Oxygen Affinity: A New Allosteric-Modulating Mechanism and Potential Use as 2,3-BPG Functional Substitutes."Sci Rep-Uk. 2017 Jul;7(1):1-15 19. Zhang, Nating, et al. "Pharmacokinetics-based identification of potential therapeutic phthalides from XueBiJing, a Chinese herbal injection used in sepsis management." Drug Metabolism and Disposition 46.6 (2018): 823-834.DOI: https://doi.org/10.1124/dmd.11 18. 朱琳,劉東升,朱旭江,蘇蕊,姚世霞,賀軍權(quán),楊平榮.當(dāng)歸腹痛寧滴丸質(zhì)量標(biāo)準(zhǔn)提高[J].中國(guó)民族民間醫(yī)藥,2020,29(20):32-38. 17. 彭桐,王引權(quán),張亞麗,荔淑楠,雒軍,馬琴國(guó).臨洮當(dāng)歸與岷縣當(dāng)歸8種有效成分比較[J].甘肅中醫(yī)藥大學(xué)學(xué)報(bào),2020,37(06):29-33. 16. 劉葭. 當(dāng)歸湯用于炎癥相關(guān)結(jié)直腸癌預(yù)防有效物質(zhì)研究與多元釋藥系統(tǒng)構(gòu)建[D].北京中醫(yī)藥大學(xué),2020. 15. 程江雪, 唐志書, 郭東艷, et al. 不同配伍配比對(duì)赤芍-當(dāng)歸藥對(duì)中10個(gè)成分溶出量的影響研究[J]. 藥物分析雜志, 2019, v.39(09):73-80. 14. 張競(jìng)之, 趙丹青, 王正蓉,等. 一測(cè)多評(píng)法同時(shí)測(cè)定瑤藥月里瑤秘噴霧劑中7種有效成分的含量[J]. 中國(guó)藥房, 2020(9). 13. 姚洪娟, 趙長(zhǎng)躍, 姜路晴,等. 朝藥東當(dāng)歸的生藥學(xué)及指紋圖譜研究[J]. 中藥材, 2018(6):1384-1390. 12. 荔淑楠, 王引權(quán), 馬麗麗,等. 當(dāng)歸平衡脫水干燥工藝優(yōu)化[J]. 中成藥, 2020, v.42(03):135-142. 11. 黃美松, 劉鵬, 王詩(shī)才,等. 藁本內(nèi)酯抑制血管緊張素Ⅱ誘導(dǎo)的心肌肥大及其作用機(jī)制[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志, 2016, 022(013):150-155. 10. 周晶, 李玲, 王冰,等. 葛根復(fù)方揮發(fā)油和水溶性成分提取工藝的優(yōu)化[J]. 中成藥, 2017(3). 9. 王振恒, 王引權(quán), 樊秦,等. 紫外線-B輻射對(duì)當(dāng)歸苯酞類成分含量的影響[J]. 甘肅中醫(yī)藥大學(xué)學(xué)報(bào), 2019(6). 8. 楊琪琪, 朱旭江, 王蘭霞,等. 生化丸質(zhì)量標(biāo)準(zhǔn)提高研究[J]. 中獸醫(yī)醫(yī)藥雜志, 2020, v.39;No.220(01):56-60. 7. 周晶, 李玲, 崔冬雪,等. 正交試驗(yàn)法優(yōu)選葛根復(fù)方中揮發(fā)油的β-環(huán)糊精包合工藝[J]. 時(shí)珍國(guó)醫(yī)國(guó)藥, 2017(01):113-116. 6. 周晶, 李玲, 王冰,等. 正交試驗(yàn)優(yōu)選平唐復(fù)方的醇提工藝和水提工藝[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志, 2016(22):26-30. 5. 張慶, 茹慶國(guó), 彭宇,等. 當(dāng)歸揮發(fā)油結(jié)腸靶向微丸在大鼠消化道內(nèi)的釋放行為[J]. 北京中醫(yī)藥大學(xué)學(xué)報(bào), 2016, 39(010):855-859. 4. 閆孟琳, 丁國(guó)鈺, 叢龍飛,等. 基于質(zhì)量標(biāo)志物的當(dāng)歸血管舒張功效的近紅外快速評(píng)價(jià)[J]. 中草藥, 2019, v.50;No.654(19):27-35. 3. 茹慶國(guó) 彭宇 馬書偉 等. 響應(yīng)面分析法優(yōu)化當(dāng)歸超臨界提取物結(jié)腸定位微丸的制備工藝研究[J]. 中國(guó)中藥雜志 2016(13):2442-2448. 2. 郭江玉 孫磊 閆彥 等. 合煎與單煎對(duì)四物湯中4種化學(xué)成分溶出量的影響[J]. 天津中醫(yī)藥大學(xué)學(xué)報(bào) 2017(5). 1. 張興盈 辛延蓉 蔡良輝 林亞蒙 楊野 魯惠珍 崔秀明 劉藝 王承瀟 曲媛.云當(dāng)歸干燥特性及動(dòng)力學(xué)研究[J].安徽農(nóng)業(yè)科學(xué) 2017 45(05):102-106+178.